Tatva Chintan Pharma Chem Ltd IPO

Tatva Chintan Pharma Chem Ltd IPO

Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.

Competitive Strengths:

  • Leading manufacturer of structure directing agents and phase transfer catalyst.
  • Diversified product portfolio.
  • Global market presence with customer base across industries.
  • Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
  • Experienced promoters and managers team.
  • Strong financial performance track record.

Company Promoters:

  • Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.

Company Financials

Particulars For the year/period ended (Rs in Million)
Summary of financial Information (Restated) 31-Mar-21 31-Mar-20 31-Mar- 19
Total Assets  3,148.03  2,489.38   1,875.08
Total Revenue  3,062.92   2,646.22  2,068.01
Profit After Tax  522.62  377.89  205.43


Objects of the Issue:

 

  • Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
  • Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
  • To meet general corporate purposes.

(Read Detailed Report)


Issue Details


ISSUE OPENS
Friday, July 16, 2021

ISSUE CLOSES
Tuesday, July 20, 2021

ISSUE SIZE
Rs 1073 - Rs 1083 Per Equity Share.

BID LOT
13 Equity shares & multiple of 13 Equity shares thereafter.

IPO SIZE
Rs. 500 Cr

LISTING EXCAHNGES
NSE & BSE

ALLOTMENT DATE
Tentatively Tuesday, July 27, 2021

RATIOS
QIB 50% - Retail 35% - NIB 15%

Apply Now

You can Invest via:

  201404210316526522603845   201404210316526522603171   201404210316526522603762   201606080432378699589304.jpg

Open Account Now